Tscan Therapeutics Inc Share Price

NASDAQ: TCRX

Small Cap

$1.61

-0.11

(-6.40%)

as on September 18, 2025 at 1:29 am IST

$₹

Tscan Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.6
Day's Price Range
$1.74
$1.61
0.62%
Downside
8.07%
Upside
52 Week's Low
52 Week's High
$1.02
52-Week Price Range
$6.23
$1.61
36.65%
Downside
286.65%
Upside

Tscan Therapeutics Inc share price movements today

Previous Close: $1.72
Open: $1.73
Volume: 483.5K
Day's Low - High: $1.6 - $1.74
52 Week Low - High: $1.02 - $6.23

Tscan Therapeutics Inc Historical Returns

1 Month Return: -4.44 %
3 Month Return: + 11.69 %
1 Year Return: -68.44 %
3 Year Return: -41.1 %
5 Year Return: 0 %

Tscan Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tscan Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$95.9M

EPS (TTM)

-1.2496

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.63

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-141.1M

Revenue (TTM)

7.0M

Profit Margin

0.00%

Return On Equity TTM

17253800.00%

Tscan Therapeutics Inc Stock Valuation

Track how Tscan Therapeutics Inc P/E has moved over time to understand its valuation trends.

Tscan Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (-2.63x)

September 17, 2025

Highest (-0.45x)

March 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -2.63x

Tscan Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tscan Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tscan Therapeutics Inc	BUY	$95.9M	NA	-2.63	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Tscan Therapeutics Inc Stock including INR - Dollar returns

The Tscan Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tscan Therapeutics Inc investment value today

Current value as on today

₹34,140

Returns

₹65,860

(-65.86%)

Returns from Tscan Therapeutics Inc Stock

₹70,459 (-70.46%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Tscan Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Tscan Therapeutics Inc. Average target price of $8.57

Tscan Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Tscan Therapeutics Inc.

What analysts predicted

81.21%UPSIDE

Target Price

$8.57

Current Price

$1.61

Analyzed by

12 Analysts

Target

$8.57

Tscan Therapeutics Inc target price $8.57, a slight upside of 81.21% compared to current price of $1.61. According to 12 analysts rating.

Tscan Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Tscan Therapeutics Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-31% versus previous 30 day period

Tscan Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	6	3	3	7	0	0	1	0	2	3
Gross Profit	5	1	2	5	0	0	1	0	2	3
Operating Income	-22	-24	-24	-21	-31	-34	-32	-36	-36	-38
EBITDA	-20	-21	-20	-17	-27	-29	-27	-34	-32	-35
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	1	1	1	1	1	0	0	0
Income Before Tax	-22	-24	-22	-19	-30	-31	-29	-35	-34	-36
Income Tax Expense	1	1	-1	-1	-1	-1	-	1	-	-
Net Income	-22	-24	-22	-19	-30	-31	-29	-35	-34	-36
Net Profit Margin	-331.66%	-763.82%	-591.64%	-271.99%	-5325.44%	-5906.90%	-2849.09%	-5384.81%	-1571.95%	-1201.30%

Tscan Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	1	10	13	21	2
Gross Profit	0	-19	6	8	-67	2
Operating Income	-14	-26	-48	-66	-93	-134
EBITDA	-13	-25	-45	-59	-80	-119
Interest Expense	-	-	0	1	3	3
Depreciation	0	1	3	5	5	4
Income Before Tax	-13	-26	-48	-66	-89	-127
Income Tax Expense	0	0	3	0	5	-
Net Income	-13	-26	-48	-65	-89	-127
Net Profit Margin	0.00%	-2398.25%	-479.49%	-486.19%	-423.86%	-4527.66%

Tscan Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-24	-22	-19	-30	-31	-29	-35	-34	-36
Operating Cash Flow	-22	8	-23	-29	-26	-27	-27	-37	-33
Investing Cash Flow	0	-61	1	36	-33	-82	27	13	48
Financing Cash Flow	135	0	0	0	161	1	45	0	0
Change in Cash	113	-53	-21	7	101	-109	45	-24	15

Tscan Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-26	-48	-66	-89	-127
Operating Cash Flow	-3	-48	-66	-61	-110
Investing Cash Flow	-4	-9	-4	-60	-52
Financing Cash Flow	0	189	29	135	208
Change in Cash	-6	131	-41	13	45

Global Institutional Holdings in Tscan Therapeutics Inc

Funds	Holdings
Bvf Inc	8.64%
BlackRock Inc	8.62%
Adage Capital Partners Gp LLC	6.18%
Baker Bros Advisors LP	4.92%
Vanguard Group Inc	4.16%

See all

Insights on Tscan Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 665.0K → 3.07M (in $), with an average increase of 49.4% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 157.6%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 136.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -34.12M → -36.95M (in $), with an average decrease of 8.3% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, TCRX stock has moved down by -6.5%

About Tscan Therapeutics Inc

harnessing novel t cell systems to extend the promise of immunotherapy

Organisation	Tscan Therapeutics Inc
Headquarters	830 Winter Street, Waltham, MA, United States, 02451
CEO	Dr. Gavin MacBeath Ph.D.
E-voting on shares	Click here to vote

Key Management of Tscan Therapeutics Inc

Name	Title
Dr. Shrikanta Chattopadhyay M.D.	Senior VP & Head of Translational Medicine
Dr. Gavin MacBeath Ph.D.	CEO & Director
Mr. Tomasz Kula Ph.D.	Co-Founder & Member of Advisory Board
Mr. Leiden Dworak M.B.A.	Principal Accounting Officer
Dr. Justin McCue Ph.D.	Chief Technology Officer
Ms. Ann Hargraves	Senior Vice President of Human Resources
Mr. Jason A. Amello CPA	CFO & Treasurer
Dr. Chrystal U. Louis M.D., M.P.H.	Chief Medical Officer
Dr. Stephen J. Elledge Ph.D.	Co-Founder & Chairman of Scientific Advisory Board
Dr. Zoran Zdraveski J.D., Ph.D.	Chief Legal & Strategy Officer and Company Secretary

FAQs

What is Tscan Therapeutics Inc share price today?

Tscan Therapeutics Inc share price today is $1.61 as on September 18, 2025 at 1:29 am IST at the close of the market. Tscan Therapeutics Inc share today touched a day high of $1.74 and a low of $1.6.

What is the 52 week high and 52 week low for Tscan Therapeutics Inc share?

Tscan Therapeutics Inc share touched a 52 week high of $6.23 on November 7, 2024 and a 52 week low of $1.02 on April 9, 2025. Tscan Therapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.61,which is 74.14% down from its 52 week high and 57.84% up from its 52 week low.

What is Tscan Therapeutics Inc's market capitalisation today?

Tscan Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Tscan Therapeutics Inc Stock (TCRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tscan Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tscan Therapeutics Inc Shares that will get you 0.9317 shares as per Tscan Therapeutics Inc share price of $1.61 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tscan Therapeutics Inc Stock (TCRX) from India?

Indian investors can start investing in Tscan Therapeutics Inc (TCRX) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 4:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Tscan Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:37 am IST). Based on Tscan Therapeutics Inc share’s latest price of $1.61 as on September 18, 2025 at 1:29 am IST, you will get 6.2112 shares of Tscan Therapeutics Inc. Learn more about fractional shares .